Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Name of product and/or technology Nucleic Acid and Method for the Production of Polyunsaturated Fatty Acids in Transgenic Organisms Background Fatty acids are carboxylic acids with long-chain hydrocarbon side groups that play a fundamental role in many biological processes. They can be divided into two groups: saturated fatty acids, formed of single carbon bonds, and unsaturated fatty acids, which contain one or more double carbon bonds. Unsaturated fatty acids are produced by terminal desaturases which catalyze the formation of double bonds between the carbon atoms of a fatty acid molecule. Polyunsaturated fatty acids (PUFAs) have 2 to 6 double bonds and preferably from 18 to 24 carbon atoms in the chain. Long chain PUFAs (LCPUFAs) have from 20 to 24 carbon atoms in the fatty acid chain. Generally, the controlling steps in the production of LCPUFAs are catalyzed by membrane-associated fatty acid elongase complexes. The complex consists of 4 components with different catalytic functions: the keto-acyl-CoA-5 synthase; the keto-acyl-CoA-reductase; the dehydratase; and the enoly-CoA-reductase. LCPUFAs are essential components of cell membranes of various tissues and organelles in mammals. However, mammals have a limited spectrum the enzymes required for the formation of particular double bonds in unsaturated fatty acids and must take up these essential fatty acids via food. Starting with these precursors, the physiologically important arachidonic acid (ARA), an ω6-fatty acid and the two ω3-fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are synthesized via a sequence of desaturase and elongase reactions. EPA and DHA play a role in reducing our risk to cardiovascular disease and related precursor conditions. The major sources of PUFAs in human diet are oils from fish and algae but there is increasing demand for alternative sources as the supply of fish oil is highly variable and the algal source of oil is expensive. Higher plants comprise PUFAs such as linoleic acid and linolenic acid but do not have the necessary enzymes to catalyse the elongation reaction for the production of LCPUFAs. The production of LCPUFAs in higher plants (preferably in oil crops such as oilseed rape, linseed, sunflower and soybeans) would allow high-quality LCPUFAs to be economically produced. A potential route is via recombinant methods, where genes which code for enzymes of the biosynthesis of LCPUFAs are introduced and expressed into plants. This patent takes research to the next level where marine equivalent EPA can be produced in a plant. As such this is a major step forward. Technology The inventor has been involved with cutting-edge research focused on defining the molecular basis of LCPUFAs biosynthetic pathway in marine microbes for over a decade and has successfully demonstrated the production LCPUFAs in transgenic plants via iterative metabolic engineering. The present invention relates to a nucleic acid derived from Perkinsus marinusi, an oyster protozoan parasite capable of synthesizing saturated and unsaturated fatty acids, including ARA, via the [Delta]8-desaturase pathway. In this way the invention delivers high quality EPA to the plant. The nucleic acid encodes a [Delta]9-elongase, a [Delta]8-desaturase and a [Delta]5-desaturase enzyme; the invention relates to the individual coding sequences and proteins encoded by these sequences as well as to a process for converting linoleic acid to ARA. The coding sequences can be transcribed as a single transcript, which simplifies the process of transforming cells required to express all three proteins, or as separate transcripts. 1 Rothamsted Research Reference: Patent 172 The nucleic acid sequence of the invention is linked with one or more regulatory sequences in the expression cassette to enhance gene expression. In a further aspect of the invention there is provided a transgenic non-human organism comprising at least one nucleic acid, gene construct or vector according to the previous aspect of the invention. Host cells which are suitable in principle for taking up the nucleic acid, the gene product and the vector according to the invention are all prokaryotic or eukaryotic organisms. Hence, the constructs can advantageously be propagated in microorganisms, in particular in E. coli and Agrobacterium tumefaciens, under selective conditions and make possible the transfer of heterologous DNA into plants. Especially preferred plants according to the invention are oil crops such as soybean, peanut, oilseed rape, canola, linseed, hemp, evening primrose, sunflower, safflower and trees (oil palm, coconut). Transgenic plants which comprise the polyunsaturated fatty acids synthesized in the process according to the invention can advantageously be marketed directly without there being any need for the oils, lipids or fatty acids synthesized to be isolated. Alternatively, the compounds produced in the process according to the invention can also be isolated from the organisms, advantageously plants, in the form of their oils, fats, lipids and/or free fatty acids. A further embodiment according to the invention is the use of the oil, lipid, the fatty acids and/or the fatty acid composition in feedstuffs, foodstuffs, cosmetics or pharmaceuticals. Patent Information The patent is currently granted in China and is pending in India and Brazil. Licensing Opportunities Know-how licences and related consultancy opportunities are available in most countries. Licenses may be exclusive, co-exclusive, non-exclusive or sole. Licenses will normally be for commercial purposes however academic licenses are available. Rothamsted Research will retain the right to use the technology on its own projects. Commercial Research and Development licenses containing an option to commercialise following successful outcomes from a company’s R&D will also be considered. Licensing Richard Nugent (Ref. 172) Rothamsted Research Ltd Contracts & Intellectual Property Harpenden Email: [email protected] Herts Tel: +44 (0) 1582 763133 ext 2478 AL5 2JQ United Kingdom 2